XenoPort (XNPT)
Add to Watchlists Create an AlertXNPT Key Stats
| Income Statement | |
| Revenue TTM | 11.70M |
| Revenue Quarterly YoY Growth | -95.58% |
| EPS Diluted TTM | -1.063 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | -45.22M |
| Profitability | |
| Gross Profit Margin Quarterly | |
| Profit Margin Quarterly | -5130% |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 261.19M |
| Enterprise Value | 140.37M |
| PE Ratio TTM | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 2.409 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow | -21.97M |
| Return on Equity | -48.58% |
XNPT News
- XENOPORT INC Files SEC form 8-K, Other Events May 23
- Nasdaq stocks posting largest percentage decreases May 22
- XenoPort Resumes Horizant Supply - Analyst Blog Zacks May 22
- XenoPort Resumes Horizant Supply May 22
- XenoPort Candidate Disappoints - Analyst Blog Zacks May 21
- XenoPort Candidate Disappoints May 21
- XenoPort weakness creates buying opportunity, says Wells Fargo May 21
- XenoPort's CEO Presents at Special Conference (Transcript) Seeking Alpha May 20
- Why XenoPort Shares Stumbled Fool May 20
- Wedbush Downgrades XenoPort (XNPT) to Neutral Street Insider May 20
XNPT Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). XenoPort is down 6.13% over the last year vs S&P 500 Total Return up 27.45%, Vical up 26.06%, and GTx up 105.6%.
XNPT Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these XNPT related companies
Pro Ratings for XNPT
Pro Report PDF for XNPT
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download XNPT Pro Report PDF
Pro Strategies Featuring XNPT
Did XenoPort make it into our Pro Portfolio Strategies?
XNPT Profile
Sector: Healthcare
Industry: Biotechnology
Other XNPT Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| XNPT | 5.51 | +0.12 | +2.23% | 261.19M |
